(HealthDay News) — Reimbursement of home blood pressure monitoring is cost beneficial to insurers, according to a study published online in Hypertension.
Alejandro Arrieta, PhD, from the Florida International University in Miami, and colleagues developed a decision-analytic model to conduct a cost-benefit analysis from the perspective of the insurer. The 2008 to 2011 claims data of a private health insurer in the United States, data from 2009 to 2010 National Health and the Nutrition Examination Survey, and data from published meta-analyses were used as inputs for the model.
Transitions among health states (from initial physician visit to hypertension diagnosis, to treatment, to hypertension-related cardiovascular diseases and patient death or resignation from the plan) were simulated. Cost-benefit ratios and both short- and long-run return on investment for home blood pressure (BP) monitoring compared with clinic BP monitoring were estimated.
The researchers found that, depending on the insurance plan and age group categories considered, estimated net savings associated with the use of home BP monitoring ranged from $33 to $166 per member in the first year.
Long-term (10 years), the savings ranged from $415 to $1,364. The range for return on investment was $0.85 to $3.75 per dollar invested in the first year and $7.50 to $19.34 per dollar invested in the long run.
“Our results suggest that reimbursement of home BP monitoring is cost beneficial from an insurer’s perspective for diagnosing and treating hypertension,” the researchers wrote.